(Reuters) - Moderna Inc on Thursday received approval from the U.S. Food and Drug Administration (FDA) for an additional multi-dose vial of its COVID-19 vaccine in which each vial contains a maximum of 15 doses, increasing the number of doses available.
The agency also revised the number of doses per vial from its currently available vials to a maximum of 11 doses from 10.
Already a subscriber? Log in
The Star 6.6 DEAL: 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
